Husni ME, Deodhar A, Schwartzman S, Chakravarty SD, et al. Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Arthritis Res Ther 2022;24:73.
PMID: 35313978